Literature DB >> 25190610

[Chronic pain and artificial diseases].

C Roch1, C Knöchlein, J Albrecht.   

Abstract

A 34-year-old woman presented with a complex pain disorder and a previous diagnosis of the rare Gitelman syndrome but with a negative genetic test. The patient was admitted to a routine ward for treatment of the pain but was transferred to the intensive care unit after suffering severe hypokalemia and a narcoleptic attack. In the period of intensive care all blood parameters were stable but on release to the normal ward severe hypokalemia immediately reoccurred. With consent the patient's belongings were inspected and many diuretics and laxatives were found. The patient admitted to uncontrolled self-medication so that the diagnosis of Gitelman syndrome also appeared to be an artificial disorder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190610     DOI: 10.1007/s00482-014-1477-4

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  5 in total

Review 1.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

Authors:  J Hirsh; J Dalen; D R Anderson; L Poller; H Bussey; J Ansell; D Deykin
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Hereditary renal tubular disorders.

Authors:  Vimal Chadha; Uri S Alon
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

Review 3.  [Disorders of potassium balance].

Authors:  P Gross; J Passauer
Journal:  Internist (Berl)       Date:  1998-08       Impact factor: 0.743

4.  Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life.

Authors:  D N Cruz; A J Shaer; M J Bia; R P Lifton; D B Simon
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

5.  Chronic hypokalaemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare.

Authors:  U Gladziwa; R Schwarz; A H Gitter; J Bijman; H Seyberth; F Beck; E Ritz; P Gross
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.